158 related articles for article (PubMed ID: 3103301)
1. Antineoplastic drug cytotoxicity in a human bladder cancer cell line: implications for intravesical chemotherapy.
Erlichman C; Vidgen D; Wu A
Urol Res; 1987; 15(1):13-6. PubMed ID: 3103301
[TBL] [Abstract][Full Text] [Related]
2. Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity.
Groos E; Walker L; Masters JR
Cancer; 1986 Sep; 58(6):1199-203. PubMed ID: 3091241
[TBL] [Abstract][Full Text] [Related]
3. Intravesical chemotherapy: in vitro studies on the relationship between dose and cytotoxicity.
Walker MC; Masters JR; Parris CN; Hepburn PJ; English PJ
Urol Res; 1986; 14(3):137-40. PubMed ID: 3092427
[TBL] [Abstract][Full Text] [Related]
4. Intravesical chemotherapy: combination with Tween 80 increases cytotoxicity in vitro.
Parris CN; Masters JR; Walker MC; Newman B; Riddle P; English P
Urol Res; 1987; 15(1):17-20. PubMed ID: 3103302
[TBL] [Abstract][Full Text] [Related]
5. Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity.
Groos E; Masters JR
J Urol; 1986 Aug; 136(2):399-402. PubMed ID: 3090275
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.
Erlichman C; Vidgen D
Cancer Res; 1984 Nov; 44(11):5369-75. PubMed ID: 6488191
[TBL] [Abstract][Full Text] [Related]
7. In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer.
Seraphim LA; Perrapato SD; Slocum HK; Rustum YM; Huben RP
J Urol; 1991 Mar; 145(3):613-7. PubMed ID: 1900087
[TBL] [Abstract][Full Text] [Related]
8. Bladder epithelial hyperplasia in F344 rats after intravesical instillation of the antitumor chemotherapeutic agents Adriamycin and mitomycin C.
Shibata MA; Hasegawa R; Kurata Y; Yamada M; Tamano S; Fukushima S
Cancer Lett; 1990 Jan; 49(1):41-9. PubMed ID: 2105835
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant intravesical therapy based on an in vitro cytotoxicity assay in the management of superficial transitional cell cancer of the urinary bladder.
Saxena S; Agrawal U; Agarwal A; Murthy NS; Mohanty NK
BJU Int; 2006 Nov; 98(5):1012-7. PubMed ID: 17034604
[TBL] [Abstract][Full Text] [Related]
10. Intravesical chemotherapy: combination with dimethyl sulfoxide does not enhance cytotoxicity in vitro.
Walker L; Walker MC; Parris CN; Masters JR
Urol Res; 1988; 16(4):329-31. PubMed ID: 3176208
[TBL] [Abstract][Full Text] [Related]
11. Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy.
Knuchel R; Hofstadter F; Jenkins WE; Masters JR
Cancer Res; 1989 Mar; 49(6):1397-401. PubMed ID: 2493980
[TBL] [Abstract][Full Text] [Related]
12. Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.
Pu YS; Hsieh TS; Cheng AL; Tseng NF; Su IJ; Hsieh CY; Lai MK; Tsai TC
Br J Urol; 1996 Jan; 77(1):76-85. PubMed ID: 8653321
[TBL] [Abstract][Full Text] [Related]
13. Choosing the right intravesical chemotherapeutic agent. Results of an in vitro monolayer cell culture assay.
Whelan P; Flynn C; Ramsden C
Br J Urol; 1984 Dec; 56(6):655-7. PubMed ID: 6442872
[TBL] [Abstract][Full Text] [Related]
14. Two hour exposure to sodium butyrate sensitizes bladder cancer to anticancer drugs.
Wang D; Wang Z; Tian B; Li X; Li S; Tian Y
Int J Urol; 2008 May; 15(5):435-41. PubMed ID: 18452462
[TBL] [Abstract][Full Text] [Related]
15. Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay.
Tanigawa N; Mizuno Y; Hashimura T; Honda K; Satomura K; Hikasa Y; Niwa O; Sugahara T; Yoshida O; Kern DH
Cancer Res; 1984 Jun; 44(6):2309-12. PubMed ID: 6202397
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo experiments on electrochemotherapy for bladder cancer.
Vásquez JL; Ibsen P; Lindberg H; Gehl J
J Urol; 2015 Mar; 193(3):1009-15. PubMed ID: 25245485
[TBL] [Abstract][Full Text] [Related]
17. The heterogenous cytotoxic response of colon cancer cells is unrelated to phenotypic differentiation characteristics.
Drewinko B; Yang LY
Anticancer Res; 1988; 8(1):161-4. PubMed ID: 3128957
[TBL] [Abstract][Full Text] [Related]
18. [Chemosensitivity test on superficial urinary bladder cancer using the dye exclusion assay--model of intravesical chemotherapy].
Koseki K; Irisawa C; Shiraiwa Y
Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):268-73. PubMed ID: 1904118
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide.
Mizutani Y; Fukumoto M; Bonavida B; Yoshida O
Cancer; 1994 Nov; 74(9):2546-54. PubMed ID: 7923012
[TBL] [Abstract][Full Text] [Related]
20. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
Mobley WC; Loening SA; Narayana AS; Culp DA
Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
